Ista Pharmaceuticals (ISTA) Inactive 10-Q2007 Q2 Quarterly report

Filed: 2 Aug 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: abroad, abuse, adequate, advertise, advertising, AG, aggressive, agree, agreed, Alcon, alleging, Alliance, Amphastar, attract, aware, Bausch, biotechnology, Biozyme, blink, bothersome, branded, breadth, brought, BT, bulk, campaign, cancellation, cGMP, charter, civil, claim, committed, comply, complying, component, comprise, consuming, Cosmetic, coverage, criminal, DEA, deposit, depressing, difficult, discourage, discouraging, Disease, dispute, domestic, dosed, driven, educational, efficiently, Eli, enable, endpoint, ensure, entrench, entrenching, evolving, exert, exhaustive, expertise, field, freely, grow, Halozyme, importation, imprisonment, inadequate, increasingly, Index, individual, influence, inhibit, Inspire, insurance, intense, Internet, Investor, issuable, itching, Johnson, key, kill, labeling, large, largest, law, lead, leave, legislation, legislative, liberal, light, Lilly, Lomb, managerial, mandated, manner, marked, Medicaid, Medicare, Modernization, monetary, movement, network, newly, nominee, noncompetitive, notified, occurrence, OSDI, packing, payor, penalty, person, Pfizer, plant, population, postponed, PredForte, preferred, premium, PrimaPharm, prohibiting, proper, properly, publicly, qualified, quality, rapid, recall, recruit, regulation, relationship, removal, representation, resume, resumed, retail, retain, revoking, Scherer, scientific, scrutiny, serve, ship, skilled, small, sponsored, Sprout, sterile, stockholder, store, storing, strain, submission, submitted, substitute, substituted, superior, supplied, supplier, supply, suspension, symptom, takeover, team, technical, Tobradex, Tobrex, tradable, train, trained, training, trend, undergo, unsolicited, valuable, verified, volume, voting, West, withdrawal, withdrew, Zylet

Removed: account, APB, assuming, award, calculate, commencement, commensurate, enterprise, ESPP, exercised, forma, incremental, intrinsic, modified, permitted, pro, recur, restated, settled, simplified, supplemental, table, unusual

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ISTA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Certification Pursuant to Rule 13a-14(b) or Rule 15d-14(b)

of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350

I, Vicente Anido, Jr., Ph.D., hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that the Quarterly Report of ISTA Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended June 30, 2007 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q for the period ended June 30, 2007 fairly presents in all material respects the financial condition and results of operations of ISTA Pharmaceuticals, Inc.


Date: August 2, 2007		/s/ Vicente Anido, Jr., Ph.D.
		Vicente Anido, Jr., Ph.D.
		President and Chief Executive Officer